Can a Droplet Change a Patient's Cancer Treatment?

doctor and patient

QXDx AutoDG ddPCR System

Droplet Digital PCR (ddPCR) is a proven technology in clinical cancer research, with more than 3,440 publications and over 900 publications focused on liquid biopsy.

Bio-Rad's QXDx Droplet Digital PCR System utilizes a simple, user friendly, and scalable workflow to meet your throughput and sensitivity needs. The system is now FDA cleared.


Chronic Myeloid Leukemia (CML) is a manageable disease through routine monitoring of BCR-ABL.

Bio-Rad's QXDx BCR-ABL %IS Kit provides an absolute measure of BCR-ABL P210 transcripts using Bio-Rad's Droplet Digital PCR technology. The kit detects molecular response (MR) down to MR 4.7 (0.002%IS) LOD without compromising specificity.

Be the first to know when Bio-Rad's QXDx AutoDG ddPCR System and QXDx BCR-ABL %IS Kit are available in your local area

Contact a Bio-Rad sales representative today.

Thank you for your submission

IVD icon

The QXDx AutoDG ddPCR System and the QXDx BCR-ABL %IS Kit are IVD marked. Bio-Rad, QXDx, AutoDG, Droplet Digital PCR and ddPCR are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions